Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation

Spremljeno u:
Bibliografski detalji
Izdano u:Kidney Int Rep
Glavni autori: Ainley, Louise, Law, Steven, Heptinstall, Lauren, Rodriguez-Justo, Manuel, Thomson, Kirsty, Pepper, Ruth J.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2020
Teme:
Nephrology Rounds
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7783564/
https://ncbi.nlm.nih.gov/pubmed/33426402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2020.10.012
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items